Skip to main content

Rivotril - Further shortage

Last Updated: Mon, 24/10/2022 - 17:35

Epilepsy Ireland has been notified by the Health Products Regulatory Authority (HPRA) that further issues are expected with the supply of the Anti-Seizure medication, Rivotril (Clonazepam).

In September, manufacturing issues created a shortage of the medication and led to difficulties for many patients in having their prescriptions filled. Although supply had returned to normal in recent weeks, it now appears that further shortages are likely.

You can see the full update we have received from the HPRA below:

We have been notified of a shortage of Rivotril 0.5mg Tablets; the product has gone out of stock last week and resupply is expected in late November. The company that places the product on the market has informed us there has been a manufacturing delay which is affecting multiple countries. The sooner-than-expected nature of depletion is also likely in part due to back-orders and there may still be stock remaining in pharmacies/hospitals.

The issue had been raised at European level. We have also flagged the shortage to the HSE as clinical guidance is not within our remit.”

If you or a family member are currently taking Rivotril, please speak to your medical team as soon as possible. The use of anti-seizure medications is a clinical decision, and only your clinical team will be able to advise on potential alternatives.

We will provide any further updates we receive on our website and social media channels.